What is Tumor Necrosis Factor (TNF) and which cells release it?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 3, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

What is Tumor Necrosis Factor (TNF) and Which Cells Release It?

TNF (Tumor Necrosis Factor) is a proinflammatory cytokine produced primarily by activated macrophages and monocytes, though a wide variety of cell types including keratinocytes, epithelial cells, and lymphocytes also release it. 1

Cellular Sources of TNF

Primary producers:

  • Monocytes and macrophages are the predominant cellular sources of TNF-α 1, 2
  • Activated T lymphocytes produce TNF as part of the adaptive immune response 3, 4
  • Keratinocytes (skin cells) produce TNF and contribute to inflammatory skin conditions like psoriasis 1
  • Epithelial cells release TNF during acute inflammation 1

Secondary producers:

  • Neutrophils can produce TNF during inflammatory responses 1
  • Natural killer (NK) cells contribute to TNF production 1
  • Various other immune cells release TNF when activated 5

Forms and Mechanisms of TNF

TNF exists in two biologically active forms: 1

  • Transmembrane TNF (tmTNF): Cell surface-bound precursor form that remains attached to the cell membrane
  • Soluble TNF (sTNF): Released into circulation after enzymatic cleavage from tmTNF

Both forms bind to two distinct receptors: 1, 2

  • TNF receptor 1 (TNFR1, p55)
  • TNF receptor 2 (TNFR2, p75)

Primary Functions of TNF

Proinflammatory activities: 1

  • Promotes leukocyte extravasation (movement of white blood cells from blood vessels into tissues)
  • Induces fever through direct effects on the central nervous system 6
  • Promotes vasodilation to increase blood flow to inflamed areas

Immune modulation: 1

  • Up-regulates other inflammatory mediators through NF-κB activation, which promotes inflammation 1, 7
  • Controls intracellular infections including mycobacteria and certain fungi 1
  • Activates neutrophils and eosinophils as part of the immune response 5

Cellular effects: 2, 7

  • Can induce cell apoptosis (programmed cell death) depending on cellular context
  • Modulates expression of adhesion molecules (E-selectin, ICAM-1) responsible for leukocyte migration 2
  • Regulates production of other cytokines including IL-6 2

Metabolic effects: 1

  • Alters lipid metabolism 5
  • Can cause cachexia (wasting syndrome) in chronic disease states 8, 5

Pathological Roles

TNF plays a central role in multiple disease states: 1

  • Rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis (elevated TNF in affected joints and tissues) 1, 9
  • Psoriasis (elevated TNF in involved skin) 1
  • Inflammatory bowel disease 9

Excessive TNF production contributes to: 6, 8

  • Septic shock through dysregulated inflammatory response (though TNF does not directly stimulate septic shock itself) 6
  • Autoimmune diseases 8
  • Tumor cachexia 8, 5

Clinical Significance

TNF inhibitors are FDA-approved treatments for multiple inflammatory conditions, including etanercept, infliximab, and adalimumab, which work by binding TNF-α and preventing its interaction with cell surface receptors 9, 2

Critical warning: Blocking TNF significantly increases risk of serious infections, particularly tuberculosis reactivation, invasive fungal infections, and nontuberculous mycobacterial infections, because TNF is essential for controlling intracellular pathogens 1, 9

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Clinical applications of tumour necrosis factor.

Progress in growth factor research, 1989

Guideline

Cytokine Functions and Septic Shock

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Tumor necrosis factor.

Cancer letters, 2013

Guideline

Tumor Necrosis Factor Inhibitors for Immune-Mediated Inflammatory Diseases

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.